Icon
WORLD HEALTH ORGANISATION LEAFLET ON PREVENTION BOTULISM FOOD POISONING, 2013

[su_expand height="30" link_style="dotted" link_align="left" more_icon="icon: chevron-down" less_icon="icon: chevron-up"]
Protect your family: make sure your food is safe! Prevent botulism food poisoning when processing and preserving foods at home.
[/su_expand]

Icon
ENTEROSGEL COLUMBIA LECTURE, 2016 (Part 2)

[su_expand height="30" link_style="dotted" link_align="left" more_icon="icon: chevron-down" less_icon="icon: chevron-up"]A.V.Khovanov
Innovative Gastro-absorption method. A novel cleansing system in prevention and treatment.
[/su_expand]

Icon
SYNDROME OF ENDOGENOUS INTOXICATION IN PATIENS WITH LIVER CIRRHOSIS AND COMORBID INTESTINAL DYSBIOSIS, 2013

[su_expand height="30" link_style="dotted" link_align="left" more_icon="icon: chevron-down" less_icon="icon: chevron-up"]Gavrysh I. M. VISNYK VDNZU «Ukrai'ns'ka medychna stomatologichna akademija»

Conclusions. Patients with liver cirrhosis and comorbid intestinal dysbiosis show significant changes in biochemical parameters as improving MMP on the background of nucleotide - peptide index reduction in serum, indicating the presence of SEI in the studied patients. The combined treatment of patients with liver cirrhosis and intestinal dysbiosis by medication of «LB» and «MAH» leads to the normalization of these indicators by SEI eliminating.
[/su_expand]

Icon
APPLICATION OF ENTEROSGEL ENTEROSORBENT FOR TREATMENT OF INTOXICATION AND DIARRHEA SYNDROMES IN PATIENTS WITH AIDS DURING ANTIRETROVIRAL THERAPY, 2015

Yurchenko A.V., Nikolaev V.G., Mamyedova E.S., Antonenko Z.V., Fedorenko S.V., Riabokon S.V., Harytonyuk A.V., Babeshko Y.S.

[su_expand height="30" link_style="dotted" link_align="left" more_icon="icon: chevron-down" less_icon="icon: chevron-up"]1. Application of Enterosgel enterosorbent in the patients with AIDS in the development of adverse reactions to antiretroviral therapy promotes more rapid reduction of diarrhea and intoxication syndrome (disappereance of subjective complaints, reduction of mean values of intoxication indexes, rod nuclear cells and eosinophils, positive dynamics of reduce of transaminase average level).
2. No adverse reactions caused by Enterosgel has been identified during its application as a part of complex therapy of pathological conditions in HIV-infected patients.[/su_expand]

Icon
ENTEROSORBENT ENTEROSGEL IN CLINICAL PRACTICE, 2016

T. Miksa

[su_expand height="30" link_style="dotted" link_align="left" more_icon="icon: chevron-down" less_icon="icon: chevron-up"]ln order to assess the characteristics of the medical device ENTEROSGEL, establish the method of its use and the safety for users, this report was drawn up in the form of a critical evaluation of the relevant
published clinical studies conducted with ENTEROSGEL and with other at least partially comparable
medical devices already placed on the European market.

-Translation from the Czech language-[/su_expand]

Icon
EFFICIENCY OF ENTEROSGEL IN CORRECTION OF SYSTEMIC ENDOTOXEMIA IN CHILDREN WITH ATOPIC DERMATITIS, 2016

T.G. Malanicheva, B.A. Shamov

[su_expand height="30" link_style="dotted" link_align="left" more_icon="icon: chevron-down" less_icon="icon: chevron-up"]Endotoxin aggression is developed with the expressed release of endotoxin (ET) in the bloodstream on the background of insufficient activity of excretory systems and is qualified as a universal mechanism involved in the pathogenesis of many infectious and non-infectious diseases [1]. Systemic endotoxemia can develop as a result of both inactive intestinal microbiota, constant permeability disorders of the intestinal mucous membranes, and pancreatic insufficiency, biliary duct insufficiency, depression of liver barrier function or reduced portal blood flow, etc [2]. ET presence affects immunocompetent blood cells and is one of the considerable stimulation factors of the immune system. Under physiological conditions, anti-endotoxin antibodies are released in response to ET presence [3]. In pathological endotoxemia a decline of adaptive capacity and body resistance takes place [4, 5]. It is also known that endotoxemia causes cellular hypoxia, metabolic disorders, activation of sympathetic nervous system, complement system, resulting in lysis of leukocytes and platelet aggregation with the release of biologically active substances - kinins, histamine, serotonin, causing "mediator chaos."

All of the above has allowed us to make an assumption about the importance of systemic endotoxemia and endotoxin aggression in atopic dermatitis (AD) in children.

Objective: to define level of systemic endotoxemia in children with AD and evaluate drug Enterosgel (polymethylsiloxane polyhydrate) in complex therapy of the pathology.[/su_expand]

Icon
SAFETY DATA SHEET

Bioline Products s.r.o.

Icon
ABOUT EXPERIMENTAL PRECLINICAL SAFETY STUDYING OF THE MEDICINAL FORM OF A PREPARATION «ENTEROSGEL®,PASTE FOR INTAKE (SWEET)» GIVEN «TNK SILMA LTD.» (MOSCOW), 2010

[su_expand height="30" link_style="dotted" link_align="left" more_icon="icon: chevron-down" less_icon="icon: chevron-up"]THE STUDY DRUG SAFETY OF "ENTEROSGEL®, PASTA FOR INTAKE (SWEET)" ALLOWS TO RECOMMEND ITS SUBMISSION TO THE TO THE MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION AS LOW-TOXICITY DRUG AS THE PROCEDURE FOR EXPANDING INDICATIONS AND CHANGES IN INSTRUCTION FOR USE. [/su_expand]

Icon
COLLECTION OF RESEARCH PAPERS. ENTEROSGEL RESEARCHES, 2015

[su_expand height="30" link_style="dotted" link_align="left" more_icon="icon: chevron-down" less_icon="icon: chevron-up"]Dzyublik I, Shunko Em, Barbova A. Clinical efficacy of Enterosgel in treatment of rotovirus infections in newborns
Gorodetsky, Tebechevsky F Clinical efficacy of Enterosgel in treatment of patients with hepatitis A
Tkachenko E., Avalueva E. The Clinical Efficacy and safety of Enterosgel in the treatment of diarrhoea-dominant irritable bowel syndrome.
Tkachenko E., Avalueva E. The Clinical Efficacy and safety of Enterosgel in the treatment of Helicobacter Pylori – associated chronic gastroduodentis
Astahov V., Gusev V. The Clinical Efficacy and safety of Enterosgel in complex prevention of fetoplacental dysfunction in pregnant women with earlier syphilis
Usenko D., Gorelov A. The Clinical Efficacy of Enterosgel, in treatment of intestinal infections in chidren with atopic dermatitis.
Radchenko V., Seliverstov P. The Clinical Efficacy and safety of Enterosgel in treatment of predialysis Cronic Renal Falure (CRF) patients.
Nakhashova V. The Clinical Efficacy of Enterosgel in treatment of patients with Chronic Pancreatitis
Karlyichuk A., Kulachek F. The Clinical Efficacy of Enterosgel in complex treatment and prophylaxis of post-operative intraperitoneal in complication of acute cholecystitis
Moroz L., Paliy M. Use of enterosorbent Enterosgel in complex therapy of acute viral hepatitis B with concomitant intestinal dysbiosis
Sokolov E., Majev I. Clinical efficacy of Enterosgel in patients with digestive system-relative pathology.
Paliy I., Tchernobroviy V. Clinical efficacy of Enterosgel in complex treatment of intestinal dysbiosis
Yurchenko A., Nikolaev V. Clinical efficacy of Enterosgel in treatment of intoxication and diarrhoea in patients with AIDS during antiretroviral therapy. [/su_expand]

Icon
COLLECTION OF RESEARCH PAPERS. GASTROENTEROLOGY: NEW APPROACHES, 2014

[su_expand height="30" link_style="dotted" link_align="left" more_icon="icon: chevron-down" less_icon="icon: chevron-up"]Paliy I.G., Reznichenko I.G. A Modern View on the Issue of Enterosorption: Choosing the O ptimal Drug
Tkach S.M. Effectiveness of Enterosorbent Enterosgel in Combined Anti-Helicobacter Therapy for Patients with Peptic Ulcer Disease
Osadchaya O.I., Boyarskaya A.M. Clinical Effectiveness of Enterosorption in Reduction of Endogenous Intoxication Syndrome in Patients with Nonspecific Ulcerative Colitis
Osadchaya O.I., Shmatova E.A., Boyarskaya A.M. Role of Detoxification Therapy in Maintaining Toxin-binding Capacity of Peripheral Blood Albumin in Patients with Alcoholic Liver Disease
Zaytseva N.V., Aminova A.I., Akatova A.A., Minchenko Ye. Yu. Peculiarities of Eradication Therapy for Chronic H. pylori-associated Gastroduodenitis in Children Living in Ecologically Unfavorable Conditions
Fedorova O.V., Fedulova E.N., Tutina O.A., Korkotashvili L.V. Endogenous Intoxication in Inflammatory Bowel Disease in Children: Substantiation of Detoxification Therapy Using Enterosorption Method
Boyarskaya A.M., Osadchaya O.I., Zhernov A.A., Kovalenko O.N.Use of Enterosorbent Enterosgel in Combination Treatment of Intestinal Dysbiosis in Children with Burn Disease
Enterosgel® in Gastroenterology: Posology and Method of Administration
Dosage and Administration of Enterosgel® for the Treatment of Acute Diarrhea [/su_expand]

 


Please rate this information
  • 0/5
  • 0 ratings
0 ratingsX
Very bad! Bad Hmmm Oke Good!
0% 0% 0% 0% 0%